Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 716 (USA) (Dr. Ito)
· consented 2014-05-14
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate ABDOMINAL PAIN — outcome: RECOVERED/RESOLVED; onset 2014-07-22 (study day 70.0); relationship: NONE
mild
assessed
2026-08-18
Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-28 (study day 15.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2014-05-28 (study day 15.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate ULCER — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-08-02 (study day 81.0); relationship: NONE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.